Table 1 Participant demographic and clinical characteristics
From: Brain responses to body image stimuli but not food are altered in women with bulimia nervosa
|  | HC (n = 23) | BN (n = 21) | HC vs BN |
|---|---|---|---|
Age (in yrs) | 27.3 ± 5.1 | 28.0 ± 7.1 | NS |
BMI (kg/m2) | 21.3 ± 2.4 | 23.4 ± 5.0 | NS |
Hours since last meal | 3.6 ± 2.8 | 5.5 ± 4.3 | NS |
Number on OC | 8/23 (35%) | 6/21 (29%) | NS |
Not on OC in follicular menstrual phase | 9/15 (60%) | 10/15 (67%) | NS |
Number on medication, compound and dose | NA | 9/21 (43%) | NA |
1 citalopram 20mg | |||
1 citalopram 30 mg | |||
3 fluoxetine 20 mg | |||
1 fluoxetine 40 mg | |||
2 fluoxetine 60 mg | |||
1 venlafaxine 300 mg | |||
Number of smokers | 2/23 (9%) | 3/21 (14%) | NS |
History of AN | NA | 8/21 (38%) | NA |
Duration of illness | NA | 0–5 year (n = 3) | NA |
5–10 year (n = 12) | |||
10–15 year (n = 3) | |||
>15 year (n = 3) | |||
EDE-Q total | 0.6 ± 0.5 | 4.8 ± 0.7 | t(1,43) = 24.4; p < 0.01 |
EDE-Q restraint | 0.4 ± 0.5 | 4.5 ± 0.9 | t (1,43) = 18.7; p < 0.01 |
EDE-Q eating concerns | 1.1 ± 0.3 | 4.2 ± 0.2 | t (1,43) = 17.0; p < 0.01 |
EDE-Q weight concerns | 0.7 ± 0.7 | 5.1 ± 0.8 | t(1,43) = 19.8; p < 0.01 |
EDE-Q shape concerns | 1.0 ± 0.8 | 5.3 ± 0.7 | T(1,43) = 19.1; p < 0.01 |
DASS-21 total (range 0–86) | 19.0 ± 6.5 | 74.4 ± 29.0 | t(1,43) = 8.3; p < 0.01 |
DASS-depression (range 0–42) | 5.4 ± 5.4 | 23.4 ± 11.6 | t(1,43) = 6.7; p < 0.01 |
DASS-anxiety (range 0–42) | 3.4 ± 4.0 | 23.2 ± 11.4 | t(1,43) = 7.9; p < 0.01 |
DASS-stress (range 0–42) | 11.2 ± 7.6 | 27.8 ± 9.6 | t(1,43) = 6.4; p < 0.01 |
FCQ-Trait (range 39–236) | 77.6 ± 17.3 | 159.4 ± 27.1 | t(1,43) = 12.1; p < 0.01 |
FCQ-State (range 15–75) | 25.4 ± 7.9 | 43.5 ± 12.3 | t(1,43) = 5.9; p < 0.01 |
SAAS (range 0–80) | 26.7 ± 8.4 | 64.3 ± 11.0 | t(1,43) = 12.9; p < 0.01 |
PACS (range 0–25) | 14.1 ± 3.6 | 21.3 ± 2.4 | t(1,43) = 7.7; p < 0.01 |